References
- Mascherbauer J, Maurer G. The forgotten valve: lessons to be learned in tricuspid regurgitation. Eur Heart J. 2010;31(23):2841–2843. Epub 2010 Aug 20. PMID: 20729224. doi: 10.1093/eurheartj/ehq303
- Arsalan M, Walther T, Smith RL 2nd, et al. Tricuspid regurgitation diagnosis and treatment. Eur Heart J. 2017;38(9):634–638. PMID: 26358570. doi: 10.1093/eurheartj/ehv487
- Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953–2960. PMID: 29241483. doi: 10.1016/j.jacc.2017.10.039
- Praz F, Muraru D, Kreidel F, et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021;17(10):791–808. PMID: 34796878; PMCID: PMC9724890. doi: 10.4244/EIJ-D-21-00695
- Hahn RT, Weckbach LT, Noack T, et al. Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature. JACC Cardiovasc Imaging. 2021;14(7):1299–1305. PMID: 33744134. doi: 10.1016/j.jcmg.2021.01.012
- Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57–185. PMID: 24603191. doi: 10.1016/j.jacc.2014.02.536
- Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–442. PMID: 30121261. doi: 10.1016/j.jcmg.2018.06.014
- Adler DS. Non-functional tricuspid valve disease. Ann Cardiothorac Surg. 2017;6(3):204–213. PMID: 28706863. doi: 10.21037/acs.2017.04.04
- Rogers JH, Bolling SF. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation. 2009;119(20):2718–2725. PMID: 19470900. doi: 10.1161/CIRCULATIONAHA.108.842773
- Song H, Kim MJ, Chung CH, et al. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart. 2009;95(11):931–936. PMID: 19321491. doi: 10.1136/hrt.2008.152793
- Kwak JJ, Kim YJ, Kim MK, et al. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. Am Heart J. 2008;155(4):732–737. PMID: 18371484. doi: 10.1016/j.ahj.2007.11.010
- Höke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart. 2014;100(12):960–968. PMID: 24449717. doi: 10.1136/heartjnl-2013-304673
- Anvardeen K, Rao R, Hazra S, et al. Prevalence and Significance of Tricuspid Regurgitation Post-Endocardial Lead Placement. JACC Cardiovasc Imaging. 2019;12(3):562–564. PMID: 30219404. doi: 10.1016/j.jcmg.2018.07.009
- Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67(15):1829–1845. PMID: 27081024. doi: 10.1016/j.jacc.2016.01.063
- Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18(12):1342–1343. PMID: 28977455. doi: 10.1093/ehjci/jex139
- Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13(3):240–245. discussion 245-6 PMID: 9628372. doi: 10.1016/s1010-7940(98)00014-1
- Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–2854. PMID: 26718672. doi: 10.1016/j.jacc.2015.10.018
- Oh NA, Kampaktsis PN, Gallo M, et al. An updated meta-analysis of MitraClip versus surgery for mitral regurgitation. Ann Cardiothorac Surg. 2021;10(1):1–14. PMID: 33575171. doi: 10.21037/acs-2020-mv-24
- Mehr M, Taramasso M, Besler C, et al. 1-year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve registry. JACC: Cardiovasc Interv. 2019;12(15):1451–1461. PMID: 31395215. doi: 10.1016/j.jcin.2019.04.019
- Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020;8(4):265–276. PMID: 32241534. doi: 10.1016/j.jchf.2019.12.006
- Besler C, Orban M, Rommel KP, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC: Cardiovasc Interv. 2018;11(12):1119–1128. PMID: 29929631. doi: 10.1016/j.jcin.2018.05.002
- Hammerstingl C, Schueler R, Malasa M, et al. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J. 2016;37(10):849–853. PMID: 26744457. doi: 10.1093/eurheartj/ehv710
- Braun D, Nabauer M, Massberg S, et al. Transcatheter repair of primary tricuspid valve regurgitation using the MitraClip system. JACC: Cardiovasc Interv. 2016;9(15):e153–4. PMID: 27423227. doi: 10.1016/j.jcin.2016.05.020
- Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135(19):1802–1814. PMID: 28336788. doi: 10.1161/CIRCULATIONAHA.116.024848
- Taramasso M, Hahn RT, Alessandrini H, et al. The International multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair? JACC: Cardiovasc Interv. 2017;10(19):1982–1990. PMID: 28982563. doi: 10.1016/j.jcin.2017.08.011
- Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019;394(10213):2002–2011. PMID: 31708188. doi: 10.1016/S0140-6736(19)32600-5
- Lurz P, Stephan von Bardeleben R, Weber M et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229–239. PMID: 33478646. doi: 10.1016/j.jacc.2020.11.038
- Sorajja P, Whisenant B, Hamid N, et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023;388(20):1833–1842. PMID: 36876753. doi: 10.1056/NEJMoa2300525
- Lurz P, Besler C, Schmitz T et al. Short-term outcomes of tricuspid edge-to-edge repair in clinical practice. J Am Coll Cardiol. 2023;82(4):281–291. PMID: 37207923. doi: 10.1016/j.jacc.2023.05.008
- Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017;390(10096):773–780. PMID: 28831993. doi: 10.1016/S0140-6736(17)31600-8
- Lim DS, Kar S, Spargias K, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study. JACC: Cardiovasc Interv. 2019;12(14):1369–1378. PMID: 31255562. doi: 10.1016/j.jcin.2019.04.034
- Fam NP, Braun D, von Bardeleben RS, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC: Cardiovasc Interv. 2019;12(24):2488–2495. PMID: 31857018. doi: 10.1016/j.jcin.2019.09.046
- Kitamura M, Fam NP, Braun D, et al. 12-month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Catheter Cardiovasc Interv. 2021;97(6):1281–1289. PMID: 33660364. doi: 10.1002/ccd.29583
- Kodali S, Hahn RT, Eleid MF, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021;77(4):345–356. PMID: 33509390. doi: 10.1016/j.jacc.2020.11.047
- Kodali SK, Hahn RT, Davidson CJ, et al. 1-year outcomes of transcatheter tricuspid valve repair. J Am Coll Cardiol. 2023;81(18):1766–1776. PMID: 37137586. doi: 10.1016/j.jacc.2023.02.049
- Aurich M, Volz MJ, Mereles D, et al. Initial Experience With the PASCAL Ace Implant System for Treatment of Severe Tricuspid Regurgitation. Circ Cardiovasc Interv. 2021;14(9):e010770. PMID: 34433291. doi: 10.1161/CIRCINTERVENTIONS.121.010770
- Wild MG, Löw K, Rosch S, et al. Multicenter Experience With the Transcatheter Leaflet Repair System for Symptomatic Tricuspid Regurgitation. JACC: Cardiovasc Interv. 2022;15(13):1352–1363. PMID: 35798479. doi: 10.1016/j.jcin.2022.05.041
- Ruf TF, Hahn RT, Kreidel F, et al. Short-term clinical outcomes of transcatheter tricuspid valve repair with the third-generation MitraClip XTR system. JACC: Cardiovasc Interv. 2021;14(11):1231–1240. PMID: 34112460. doi: 10.1016/j.jcin.2021.03.033
- Taramasso M, Alessandrini H, Latib A, et al. Outcomes after Current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry. JACC: Cardiovasc Interv. 2019;12(2):155–165. PMID: 30594510. doi: 10.1016/j.jcin.2018.10.022
- Hungerford SL, Rye EE, Hansen PS, et al. Key echocardiographic considerations for tricuspid valve transcatheter edge-to-edge repair. J Am Soc Echocardiogr. 2023;36(4):366–380.e1. PMID: 36754098. doi: 10.1016/j.echo.2023.01.013
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632. PMID: 34453165. doi: 10.1093/eurheartj/ehab395
- Liu X, Pu Z, Lim DS, et al. Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ transcatheter repair device-first in man implantation in China. Catheter Cardiovasc Interv. 2022;99(2):518–521. PMID: 33942968. doi: 10.1002/ccd.29687
- Liu X, Chen Y, Lim DS, et al. Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly™ device. Catheter Cardiovasc Interv. 2022;99(5):1691–1695. PMID: 35476284. doi: 10.1002/ccd.30112